VICTORY CAPITAL MANAGEMENT INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1040188 San Antonio, TX

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$96,382,169

+$78,715,825 QoQ

Shares Held

731,609

+487.4% QoQ

Ownership

0.728%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

VICTORY CAPITAL MANAGEMENT INC holds $398,774,467 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (24.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	731,609	$96,382,169
2	TEVA	Teva Pharmaceutical Industries Ltd	1,838,437	$55,373,722
3	UTHR	UNITED THERAPEUTICS Corp	60,541	$35,899,602
4	ZTS	Zoetis Inc.	295,063	$34,879,397
5	VTRS	Viatris Inc	2,394,145	$32,344,898
6	SUPN	Supernus Pharmaceuticals, Inc.	502,406	$25,969,366
7	KNSA	Kiniksa Pharmaceuticals International, plc	506,521	$24,388,985
8	COLL	Collegium Pharmaceutical, Inc	625,304	$20,678,803

All Filings in NBIX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$96,382,169	731,609	+487.4%	Shares	Sole	2026-05-15
2025-12-31	$17,666,344	124,560	-0.2%	Shares	Sole	2026-02-13
2025-09-30	$17,525,741	124,845	+34.4%	Shares	Sole	2025-11-12
2025-06-30	$11,672,075	92,864	+1.0%	Shares	Sole	2025-08-13
2025-03-31	$10,165,135	91,909	-51.6%	Shares	Sole	2025-05-02
2024-12-31	$25,920,804	189,896	-7.0%	Shares	Sole	2025-02-06
2024-09-30	$23,528,499	204,205	+48.5%	Shares	Other	2024-11-05
2024-06-30	$18,935,544	137,543	+1.2%	Shares	Sole	2024-08-05
2024-03-31	$18,738,776	135,867	+15.9%	Shares	Other	2024-05-03
2023-12-31	$15,445,038	117,221	+67.9%	Shares	Sole	2024-02-05
2023-09-30	$7,856,100	69,832	+0.7%	Shares	Sole	2023-11-06
2023-06-30	$6,541,496	69,369	-13.7%	Shares	Sole	2023-07-27
2023-03-31	$8,137,379	80,393	-29.1%	Shares	Sole	2023-05-02
2022-12-31	$13,537,090	113,338	+15.8%	Shares	Sole	2023-04-25
2022-09-30	$10,393,710	97,860	+14.7%	Shares	Sole	2022-11-02
2022-06-30	$8,317,481	85,325	-0.8%	Shares	Sole	2022-08-01
2022-03-31	$8,064,375	86,020	+417.9%	Shares	Sole	2022-05-04
2021-12-31	$1,414,503	16,608	-20.3%	Shares	Sole	2022-02-07
2021-09-30	$1,999,339	20,846	-46.8%	Shares	Sole	2021-11-02
2021-06-30	$3,812,997	39,180	-4.8%	Shares	Sole	2021-08-03
2021-03-31	$4,003,296	41,165	-89.3%	Shares	Sole	2021-05-04
2020-12-31	$36,746,589	383,376	-45.4%	Shares	Sole	2021-02-01
2020-09-30	$67,514,993	702,111	+9.2%	Shares	Other	2020-11-09
2020-06-30	$78,425,504	642,832	+12.1%	Shares	Sole	2020-08-07
2020-03-31	$49,610,546	573,201	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.